8-K
Current Report
Jasper Therapeutics, Inc. Filed Acc 0001213900-22-035178
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading ea162130-8k_jasperthera.htm…